<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01104883</url>
  </required_header>
  <id_info>
    <org_study_id>SM1-PJ-2009</org_study_id>
    <secondary_id>2009-017794-37</secondary_id>
    <nct_id>NCT01104883</nct_id>
  </id_info>
  <brief_title>The Efficacy of Adductor-Canal-Blockade on Morphine Consumption, Pain and Mobilisation After Total Knee Arthroplasty</brief_title>
  <official_title>The Efficacy of Adductor-Canal-Blockade on Morphine Consumption, Pain and Mobilisation After Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Adductor-Canal-Blockade is effective at
      reducing morphine consumption and pain, and at the same time improving mobilisation after
      total knee arthroplasty.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total morphine consumption</measure>
    <time_frame>0-24 hours postoperative</time_frame>
    <description>Total morphine consumption at the interval 0-24 hours postoperative.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total morphine consumption</measure>
    <time_frame>0-26 hours postoperative</time_frame>
    <description>Total morphine consumption at the intervals 0-2, 0-4, 0-8 and 0-26 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain during rest</measure>
    <time_frame>0-26 hours postoperative</time_frame>
    <description>0-100 mm at a visual analogue scale (VAS), at the intervals 2, 4, 8, 24 and 26 hours postoperative, and the area under the curve for the intervals 2-24 and 24-26 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain during 45 degrees active flexion of the knee</measure>
    <time_frame>0-26 hours postoperative</time_frame>
    <description>0-100 mm at a visual analogue scale (VAS), at the intervals 2, 4, 8, 24 and 26 hours postoperative, and the area under the curve for the intervals 2-24 and 24-26 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A change in pain in the placebo group</measure>
    <time_frame>24-26 hours postoperative</time_frame>
    <description>0-100 mm at a visual analogue scale (VAS), at the intervals 24 and 26 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea</measure>
    <time_frame>0-26 hours postoperative</time_frame>
    <description>Nausea scores(0-3)at 2,4,8,24,26 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Zofran consumption</measure>
    <time_frame>0-26 hours postoperative</time_frame>
    <description>Total zofran consumption at the intervals 0-24 and 24-26 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>0-26 hours postoperative</time_frame>
    <description>Seadtion score (0-3) at 2,4,8,24,26 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobilisation</measure>
    <time_frame>20-26 hours postoperative</time_frame>
    <description>Number of seconds it takes to complete the &quot;Timed Up and Go&quot; test, at 20 and 26 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative vomiting</measure>
    <time_frame>0-26 hours postoperative</time_frame>
    <description>Number of vomiting episodes at the intervals 0-2,2-4,4-8,8-24,24-26 hours postoperative.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Adductor-Canal-Blockade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adductor-Canal-Blockade with ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adductor-Canal-blockade with saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Adductor-Canal-blockade with isotonic saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adductor-Canal-Blockade</intervention_name>
    <description>US-guided Adductor-Canal-Blockade with ropivacaine 7,5 mg/ml</description>
    <arm_group_label>Adductor-Canal-Blockade</arm_group_label>
    <other_name>Naropine</other_name>
    <other_name>Postoperative pain</other_name>
    <other_name>US-guided nerve block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adductor-Canal-blockade with saline</intervention_name>
    <description>US-guided Adductor-Canal-blockade with saline</description>
    <arm_group_label>Adductor-Canal-blockade with saline</arm_group_label>
    <other_name>placebo block</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Total Knee Arthroplasty in spinal anaesthesia

          -  ASA 1-3

          -  BMI 18-40

          -  Written informed consent

        Exclusion Criteria:

          -  Can not cooperate to the exam

          -  Do not speak or understand Danish

          -  Drug allergy

          -  Alcohol or drug abuse

          -  Daily consumption of strong opioids

          -  Unable to complete the Timed Up and Go test preoperatively
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pia JÃ¦ger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesia, Privathospitalet Hamlet, Frederiksberg, Denmark</name>
      <address>
        <city>Copenhagen</city>
        <state>Frederiksberg</state>
        <zip>2000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Surgery and Anaesthesia, Glostrup Hospital</name>
      <address>
        <city>Glostrup</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2010</study_first_submitted>
  <study_first_submitted_qc>April 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2010</study_first_posted>
  <last_update_submitted>April 12, 2011</last_update_submitted>
  <last_update_submitted_qc>April 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 13, 2011</last_update_posted>
  <responsible_party>
    <name_title>Pia Jaeger MD</name_title>
    <organization>Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark</organization>
  </responsible_party>
  <keyword>Adductor-Canal-Blockade</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>US-guided nerve block</keyword>
  <keyword>total knee arthroplasty</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

